Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2017

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Chemotherapy

Oxaliplatin (130 mg/m2) was given intravenously (iv) for at least 2 h on day 1; Capecitabine (1000 mg/m2) was given orally, twice daily on days 1-14. Each cycle was 21 days. Cycles were repeated until disease progression or unacceptable toxicity.

DRUG

Herbal therapy

TLBZT based herbal decoction administered orally twice a day

Trial Locations (2)

200032

Longhua Hospital, Shanghai

404000

Chongqing Three Gorges Central Hospital, Chongqing

All Listed Sponsors
collaborator

Chongqing Three Gorges Central Hospital

OTHER

lead

Shanghai University of Traditional Chinese Medicine

OTHER

NCT01975454 - Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter